Ensign Peak Advisors
ZYME icon

Ensign Peak Advisors’s Zymeworks ZYME Stock Holding History

Ensign Peak Advisors’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-15,620
Closed -$83K – 2365
2022
Q2 		$83K Buy
15,620
+7,350
+89% +$44.4K ﹤0.01% 1997
2022
Q1 		$54K Hold
8,270
– – ﹤0.01% 2118
2021
Q4 		$136K Sell
8,270
-18,622
-69% -$388K ﹤0.01% 2009
2021
Q3 		$781K Hold
26,892
– – ﹤0.01% 1514
2021
Q2 		$933K Hold
26,892
– – ﹤0.01% 1459
2021
Q1 		$849K Buy
26,892
+9,191
+52% +$374K ﹤0.01% 1474
2020
Q4 		$837K Hold
17,701
– – ﹤0.01% 1469
2020
Q3 		$825K Buy
+17,701
New +$608K ﹤0.01% 1388

Other funds holding ZYME

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

Ensign Peak Advisors's ZYME Position: Q3 2022 in Review

Ensign Peak Advisors sold out of Zymeworks (ZYME) in Q3 2022, closing a stake of 15,620 shares — an estimated $83K sold.

Ensign Peak Advisors first reported a position in ZYME in Q3 2020 and held it in 8 quarters. The position peaked at $933K in Q2 2021. 91 funds tracked by Wall St. Rank hold ZYME as of Q3 2022.

  • Ensign Peak Advisors reported no remaining Zymeworks position as of Q3 2022 after selling out during the quarter.
  • Ensign Peak Advisors sold 15,620 Zymeworks shares in Q3 2022, an estimated $83K.
  • Ensign Peak Advisors first reported a position in Zymeworks in Q3 2020 and held it in 8 quarters.
  • Ensign Peak Advisors's Zymeworks position peaked at $933K in Q2 2021.
  • 91 funds tracked by Wall St. Rank held Zymeworks as of Q3 2022.

Based on Ensign Peak Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.